Mutation Information
Mutation Site
|
V38A |
Mutation Type
|
Amino acid level |
Gene/Protein/Region Type
|
Gp41 |
Relevant Drug
|
enfuvirtide (T20) |
Country
|
Spain |
Literature Information
PubMed PMID
|
22333046
|
Clinical information
|
Yes
|
Disease
|
HIV infection/AIDS
|
Published Year
|
2012 |
Journal
|
Retrovirology |
Title
|
The HR2 polymorphism N140I in the HIV-1 gp41 combined with the HR1 V38A mutation is associated with a less cytopathic phenotype. |
Author
|
Cunyat F,Marfil S,García E,Svicher V,Pérez-Alvárez N,Curriu M,Perno CF,Clotet B,Blanco J,Cabrera C |
Evidence
|
The HR2 polymorphism N140I in the HIV-1 gp41 combined with the HR1 V38A mutation is associated with a less cytopathic phenotypeResistance to the fusion inhibitor enfuvirtide (ENF) is achieved by changes in the gp41 subunit of the HIV envelope glycoprotein (Env).
|
|
|